Sponsor intelligence · OTHER
Clinical trials sponsored by
Xijing Hospital.
Real, source-linked trial activity for Xijing Hospital: 4 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Oct 14, 2026. Source-linked, daily-refreshed.
PHASE2 2PHASE1/PHASE2 1N/A 1
Newest Xijing Hospital trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Ofatumumab in Treatment-Refractory¬ Narcolepsy Type 1 | Ph 1/Ph 2 | RECRUITING | ↗ |
| 29d ago | Serplulimab Combined With CAPOX and Bevacizumab as Neoadjuvant Therapy | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 49d ago | A Clinical Study Comparing Anti-HER2 Therapy Combined With Chemotherap | Ph 2 | RECRUITING | ↗ |
| 57d ago | A Multicenter Prospective Observational Cohort Study for Digestive Tra | N/A | RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Xijing Hospital (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.